These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 23588948

  • 1. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
    Yang J, Liu P, Tian M, Li Y, Chen W, Li X.
    Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
    [Abstract] [Full Text] [Related]

  • 2. [Preliminary analysis of differentially expressed proteins of clear-cell renal cell carcinoma by comparative proteomic technologies].
    Yang J, Li X, Tian MJ, Wang LN, Cheng TT, Chen W.
    Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):571-6. PubMed ID: 23158988
    [Abstract] [Full Text] [Related]

  • 3. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
    Du P, Ye L, Yang Y, Jiang WG.
    Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
    [Abstract] [Full Text] [Related]

  • 4. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V, Pereira Dde A, Kalume DE, Oliveira-Carvalho AL, Ornellas AA, Soares MR, Alves G, Zingali RB.
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG, Bijenhof AM, Bosch JL, Jans JJ.
    Cancer Biomark; 2010 Jan; 7(6):261-8. PubMed ID: 21694464
    [Abstract] [Full Text] [Related]

  • 6. ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance.
    Ho PY, Chueh SC, Chiou SH, Wang SM, Lin WC, Lee IL, Yang HY, Peng HC, Lai MK.
    Urol Oncol; 2013 Oct; 31(7):1367-77. PubMed ID: 22417627
    [Abstract] [Full Text] [Related]

  • 7. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
    Hosoya N, Sakumoto M, Nakamura Y, Narisawa T, Bilim V, Motoyama T, Tomita Y, Kondo T.
    Biochim Biophys Acta; 2013 Dec; 1834(12):2630-9. PubMed ID: 23999030
    [Abstract] [Full Text] [Related]

  • 8. High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma.
    Cai MY, Luo RZ, Li YH, Dong P, Zhang ZL, Zhou FJ, Chen JW, Yun JP, Zhang CZ, Cao Y.
    Biochem Biophys Res Commun; 2012 Oct 05; 426(4):636-42. PubMed ID: 22982674
    [Abstract] [Full Text] [Related]

  • 9. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Xue S, Li QW, Che JP, Guo Y, Yang FQ, Zheng JH.
    Int J Clin Exp Pathol; 2015 Oct 05; 8(4):3765-74. PubMed ID: 26097558
    [Abstract] [Full Text] [Related]

  • 10. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X, Li H, Ma X, Li X, Gao Y, Ni D, Shen D, Gu L, Wang B, Zhang Y, Zhang X.
    Cell Biochem Biophys; 2015 Jan 05; 71(1):279-90. PubMed ID: 25120023
    [Abstract] [Full Text] [Related]

  • 11. Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma.
    Sun X, Zhang H, Luo L, Zhong K, Ma Y, Fan L, Fu D, Wan L.
    Oncol Rep; 2016 Dec 05; 36(6):3131-3138. PubMed ID: 27748938
    [Abstract] [Full Text] [Related]

  • 12. Angiomotin promotes renal epithelial and carcinoma cell proliferation by retaining the nuclear YAP.
    Lv M, Li S, Luo C, Zhang X, Shen Y, Sui YX, Wang F, Wang X, Yang J, Liu P, Yang J.
    Oncotarget; 2016 Mar 15; 7(11):12393-403. PubMed ID: 26848622
    [Abstract] [Full Text] [Related]

  • 13. [The expression and clinical significance of Annexin II in clear-cell renal cell carcinoma].
    Yang J, Cheng TT, Wang LN, Chen W, Li X.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan 15; 28(1):59-62. PubMed ID: 22230505
    [Abstract] [Full Text] [Related]

  • 14. Identification of cyclophilin A as a potential prognostic factor for clear-cell renal cell carcinoma by comparative proteomic analysis.
    Yang J, Li A, Yang Y, Li X.
    Cancer Biol Ther; 2011 Mar 01; 11(5):535-46. PubMed ID: 21368578
    [Abstract] [Full Text] [Related]

  • 15. Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Yuan J, Liu S, Yu Q, Lin Y, Bi Y, Wang Y, An R.
    Acta Histochem; 2013 Jun 01; 115(5):470-4. PubMed ID: 23245688
    [Abstract] [Full Text] [Related]

  • 16. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
    Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G.
    Clin Cancer Res; 2005 Jul 15; 11(14):5128-39. PubMed ID: 16033827
    [Abstract] [Full Text] [Related]

  • 17. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
    Du Y, Wang Q, Zhang X, Wang X, Qin C, Sheng Z, Yin H, Jiang C, Li J, Xu T.
    J Exp Clin Cancer Res; 2017 May 12; 36(1):66. PubMed ID: 28494778
    [Abstract] [Full Text] [Related]

  • 18. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S, Merseburger AS, Hennenlotter J, Scharpf M, Eyrich C, Amend B, Sievert KD, Stenzl A, Bedke J.
    BJU Int; 2012 May 12; 109(10):1565-70. PubMed ID: 21981759
    [Abstract] [Full Text] [Related]

  • 19. Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma.
    Lebdai S, Verhoest G, Parikh H, Jacquet SF, Bensalah K, Chautard D, Rioux Leclercq N, Azzouzi AR, Bigot P.
    Urol Oncol; 2015 Feb 12; 33(2):69.e11-8. PubMed ID: 25035170
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB, Ehara H, Gotoh T, Nakano M, Yokoi S, Deguchi T, Hirose Y.
    Urology; 2007 May 12; 69(5):843-8. PubMed ID: 17482919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.